Adagene Inc. (ADAG)
Nasdaq · Pharmaceutical Preparations · Inc. E9
What they're doing
Between 2026-06-21 and 2026-09-19, public records show 2 signals for Adagene Inc.. Most notable: 2026-08-04: Luo Peter (director) bought $84k of stock; 2026-09-16: Luo Peter (director) bought $64k of stock. Federal contract obligations over the last 24 months total $0. This summary was assembled automatically from SEC EDGAR, USAspending.gov, U.S. Senate lobbying disclosures and Wikimedia pageview counts.
Generated 2026-09-19 from public records.
Signals, last 12 months
- Insider purchaseLuo Peter (director) bought $64k of stock
- Insider purchaseLuo Peter (director) bought $84k of stock
Insider transactions
| Date | Insider | Role | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-09-16 | Luo Peter | director | P | 20,290 | 3.15 | $63,980 |
| 2026-08-14 | DO CUONG V | director | P | 2,000 | 3.75 | $7,500 |
| 2026-08-05 | Luo Peter | director | P | 279 | 3.65 | $1,018 |
| 2026-08-04 | Luo Peter | director | P | 22,966 | 3.65 | $83,746 |
Federal contracts
No federal contract actions on record for this recipient mapping.
Lobbying
No federal lobbying filings on record for this client mapping.
Public attention
No Wikipedia pageview data linked to this company.
Recent filings
- 2026-09-22 6-K
- 2026-09-17 4
- 2026-09-10 6-K
- 2026-09-09 6-K
- 2026-08-20 144/A
- 2026-08-19 144
- 2026-08-18 4
- 2026-08-17 4
- 2026-08-17 4
- 2026-08-17 4
- 2026-08-14 SCHEDULE 13G/A
- 2026-08-14 4
- 2026-08-12 6-K
- 2026-08-06 4
- 2026-07-06 6-K
- 2026-06-08 SCHEDULE 13D/A
- 2026-05-15 SCHEDULE 13G/A
- 2026-05-07 SCHEDULE 13G
- 2026-04-17 6-K
- 2026-04-02 424B5